The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.
Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance
Open accessAbstract
SUMMARY: There are 16 approved human immunodeficiency virus type 1 (HIV-1) drugs belonging to three mechanistic classes: protease inhibitors, nucleoside and nucleotide reverse transcriptase (RT) inhibitors, and nonnucleoside RT inhibitors. HIV-1 resistance to these drugs is caused by mutations in the protease and RT enzymes, the molecular targets of these drugs. Drug resistance mutations arise most often in treated individuals, resulting from selective drug pressure in the presence of incompletely suppressed virus replication. HIV-1 isolates with drug resistance mutations, however, may also be transmitted to newly infected individuals. Three expert panels have recommended that HIV-1 protease and RT susceptibility testing should be used to help select HIV drug therapy. Although genotypic testing is more complex than typical antimicrobial susceptibility tests, there is a rich literature supporting the prognostic value of HIV-1 protease and RT mutations. This review describes the genetic mechanisms of HIV-1 drug resistance and summarizes published data linking individual RT and protease mutations to in vitro and in vivo resistance to the currently available HIV drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–238 of 238
Mutational analysis of Lys65 of HIV-1 reverse transcriptase
Sluis‐Cremer, N., Arion, D., Kaushik, N., Lim, H. C., & Parniak, M. A. (2000) · Biochemical Journal · doi:10.1042/bj3480077 · Cited by 66
Drosopoulos, W. C., & Prasad, V. R. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4224-4230.1998 · Cited by 65
Nucleoside Reverse Transcriptase Inhibitor Resistance
Loveday, C. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200103011-00003 · Cited by 63
Tamalet, C., Yahi, N., Tourrès, C., Colson, P., Quinson, A., Poizot‐Martin, I., Dhiver, C., & Fantini, J. (2000) · Virology · doi:10.1006/viro.2000.0261 · Cited by 63
Conway, B., Wainberg, M. A., Hall, D. B., Harris, M., Reiss, P., Cooper, D. A., Vella, S., Curry, R. L., Robinson, P. A., Lange, J. M. A., et al. (2001) · AIDS · doi:10.1097/00002030-200107060-00008 · Cited by 63
Lawrence, J., Schapiro, J., Winters, M. A., Montoya, J. G., Zolopa, A. R., Pesano, R. L., Efron, B., Winslow, D. L., & Merigan, T. C. (1999) · The Journal of Infectious Diseases · doi:10.1086/314751 · Cited by 59
Shulman, N. S., Zolopa, A. R., Passaro, D. J., Murlidharan, U., Israelski, D. M., Brosgart, C. L., Miller, M. D., Doren, S. V., Shafer, R. W., & Katzenstein, D. A. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200003010-00002 · Cited by 57
Self-citationQuiñones‐Mateu, M. E., Soriano, V., Domingo, E., & Menéndez‐Arias, L. (1997) · Virology · doi:10.1006/viro.1997.8748 · Cited by 57
Duval, X., Lamotte, C., Race, E., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.570-574.2002 · Cited by 56
Resistance to Protease Inhibitors
Miller, V. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200103011-00005 · Cited by 54
The K65R Mutation Confers Increased DNA Polymerase Processivity to HIV-1 Reverse Transcriptase
Arion, D., Borkow, G., Gu, Z., Wainberg, M. A., & Parniak, M. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19860 · Cited by 53
Emini, E. A., Graham, D. J., Gotlib, L., Condra, J. H., & Byrnes, V. W. (1993) · Nature · doi:10.1038/364679b0 · Cited by 49
Mutation L210W of HIV-1 Reverse Transcriptase in Patients Receiving Combination Therapy
Yahi, N., Tamalet, C., Tourrès, C., Tivoli, N., & Fantini, J. (2000) · Journal of Biomedical Science · doi:10.1007/bf02253366 · Cited by 44
Imamichi, T., Sinha, T., Imamichi, H., Zhang, Y., Metcalf, J. A., Falloon, J., & Lane, H. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.1023-1028.2000 · Cited by 44
Closing in on HIV drug resistance.
Larder, B. A., & STAMMERS, D. K. (1999) · Nature Structural Biology · doi:10.1038/5787 · Cited by 43
Balzarini, J. M., Pelemans, H., Esnouf, R. M., & Clercq, E. D. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.255 · Cited by 43
Atkinson, B. F., Isaacson, J. D., Knowles, M. R., Mazabel, E., & Patick, A. K. (2000) · The Journal of Infectious Diseases · doi:10.1086/315726 · Cited by 43
Nucleoside Reverse Transcriptase Inhibitor Resistance
Loveday, C. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200103011-00003 · Cited by 41
Keulen, W., van Wijk, A., Schuurman, R., Berkhout, B., & Boucher, C. A. (1999) · AIDS · doi:10.1097/00002030-199907300-00011 · Cited by 40
Kuritzkes, D. R., Shugarts, D. L., Bakhtiari, M., Poticha, D., Johnson, J., Rubin, M., Gingeras, T., Kennedy, M., & Eron, J. J. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200001010-00004 · Cited by 40
Kaufmann, G. R., Suzuki, K., Cunningham, P., Mukaide, M., Kondo, M., Imai, M., Zaunders, J., & Cooper, D. A. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220151126526 · Cited by 38
Smith, M. S., Koerber, K. L., & Pagano, J. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.2.445 · Cited by 38
Smith, R. A., Remington, K. M., Preston, B. D., Schinazi, R. F., & North, T. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2335-2340.1998 · Cited by 35
Demeter, L. M., Nawaz, T., Morse, G. D., Dolin, R., Dexter, A., Gerondelis, P., & Reichman, R. C. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.6.1480 · Cited by 35
ACTG (AIDS Clinical Trials Group) 384
Smeaton, L. M., DeGruttola, V. G., Robbins, G. K., & Shafer, R. W. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00126-4 · Cited by 34
Self-citationDemeter, L. M., D’Aquila, R. T., Weislow, O. S., Lorenzo, E., Erice, A., Fitzgibbon, J. E., Shafer, R. W., Richman, D. D., Howard, T. M., Zhao, Y., et al. (1998) · Journal of Virological Methods · doi:10.1016/s0166-0934(98)00100-1 · Cited by 34
Self-citationSelmi, B., Boretto, J., Navarro, J., Sire, J., Longhi, S., Guerreiro, C., Mulard, L. A., Sarfati, S. R., & Canard, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009837200 · Cited by 33
Pérez, E., Rose, S. L., Peyser, B. D., Lamers, S. L., Burkhardt, B. R., Dunn, B. M., Hutson, A. D., Sleasman, J. W., & Goodenow, M. M. (2001) · The Journal of Infectious Diseases · doi:10.1086/318538 · Cited by 32
Jonckheere, H., Witvrouw, M., Clercq, E. D., & Anné, J. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.249 · Cited by 29
King, R. W., Winslow, D. L., Garber, S., Scarnati, H. T., Bachelor, L., Stack, S., & Otto, M. J. (1995) · Antiviral Research · doi:10.1016/0166-3542(95)00033-i · Cited by 26
Arts, E. J., Quiñones‐Mateu, M. E., Albright, J. L., Marois, J.-P., Hough, C., Gu, Z., & Wainberg, M. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4858-4865.1998 · Cited by 26
Kuritzkes, D. R., Bassett, R. L., Johnson, V. A., Marschner, I. C., Eron, J. J., Sommadossi, J., Acosta, E. P., Murphy, R. L., Fife, K. H., Wood, K., et al. (2000) · AIDS · doi:10.1097/00002030-200007280-00011 · Cited by 20
Penn, M. L., Myers, M. D., Eckstein, D. A., Liegler, T. J., Hayden, M., Mammano, F., Clavel, F., Deeks, S. G., Grant, R. M., & Goldsmith, M. A. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220151126580 · Cited by 20
Current Insights into Reverse Transcriptase Inhibitor-Associated Resistance
Wainberg, M. A., & White, A. J. (2001) · Antiviral Therapy · doi:10.1177/135965350100602s02 · Cited by 14
Walmsley, S. L., Becker, M., Zhang, M., Humar, A., & Harrigan, P. R. (2001) · Antiviral Therapy · doi:10.1177/135965350100600105 · Cited by 14
Clarke, J. R., Kaye, S., Babiker, A. G., Hooker, M., Tedder, R. S., & Weber, J. N. (2000) · Journal of Virological Methods · doi:10.1016/s0166-0934(00)00173-7 · Cited by 13
Smith, R. A., Klarmann, G. J., Stray, K. M., von Schwedler, U. K., Schinazi, R. F., Preston, B. D., & North, T. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2077 · Cited by 11
Pharmacological Exposure and the Development of Drug Resistance in HIV
Hoetelmans, R. M. W. (2001) · Antiviral Therapy · doi:10.1177/135965350100602s05 · Cited by 5
Cited by
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database
Shafer, R. W., Stevenson, D., & Chan, B. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.348 · Cited by 907
Self-citationHuman immunodeficiency virus reverse transcriptase and protease sequence database
Rhee, S.-Y. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg100 · Cited by 817
Sarrazin, C., Kieffer, T. L., Bartels, D., Hanzelka, B., Müh, U., Welker, M., Wincheringer, D., Zhou, Y., Chu, H., Lin, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.037 · Cited by 616
Wald, A., Huang, M., Carrell, D., Selke, S., & Corey, L. (2003) · The Journal of Infectious Diseases · doi:10.1086/379043 · Cited by 330
Twenty years of therapy for HIV-1 infection
Pomerantz, R. J., & Horn, D. L. (2003) · Nature Medicine · doi:10.1038/nm0703-867 · Cited by 284
Metadata
- Authors
- Shafer, R. W.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2002-04
- Volume
- 15
- Issue
- 2
- Pages
- 247-277
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2144729871
- Cited by
- 314
- References
- 238
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.